317 results on '"Mas, Emmanuel"'
Search Results
2. Treatment of pediatric heterozygous familial hypercholesterolemia 7 years after the EAS recommendations: Real-world results from a large French cohort
3. Perinatal foodborne titanium dioxide exposure-mediated dysbiosis predisposes mice to develop colitis through life
4. Promoting intestinal healing by exclusive enteral nutrition with TGF-beta in a mouse model of colitis.
5. Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes Children
6. Deciphering the interplay between biology and physics: finite element method-implemented vertex organoid model raises the challenge
7. Drugs in focus: Domperidone
8. Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives
9. Impact of the HAS 2019 French guidelines on the frequency of hospital undernutrition in children
10. Pediatric endoscopy training across Europe: a survey of the ESPGHAN National Societies Network 2016–2019
11. Factors Predicting Statin Initiation During Childhood in Familial Hypercholesterolemia: Importance of Genetic Diagnosis
12. Sa1535: EXCLUSIVE ENTERAL NUTRITION ENRICHED WITH TGF-β RESTORES INTESTINAL HOMEOSTASIS IN A MOUSE MODEL OF CROHN'S DISEASE
13. Porto-Sinusoidal Vascular Disease: A Pediatric Study of 30 Patients
14. Helicobacter Pylori-Negative Chronic Gastritis in Children
15. Training in Paediatric Clinical Nutrition Across Europe
16. Congenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions)
17. Cell Centred Finite Element Model for Intestinal Organoids Shape Analysis: From tissue architecture to mechanics
18. Hypnotherapy in Pediatric Gastroenterology
19. Long-Term Outcomes in Real Life of Lumacaftor–Ivacaftor Treatment in Adolescents With Cystic Fibrosis
20. Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
21. Functional abdominal pain disorders and patient- and parent-reported outcomes in children with inflammatory bowel disease in remission
22. Drugs in Focus
23. An ESPGHAN Position Paper on the Use of Breath Testing in Paediatric Gastroenterology
24. Systematic review and meta‐analysis: the incidence and prevalence of paediatric coeliac disease across Europe
25. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children—An Updated Review
26. Bi-allelic variants in IPO8 cause a connective tissue disorder associated with cardiovascular defects, skeletal abnormalities, and immune dysregulation
27. Cytolethal Distending Toxin Promotes Replicative Stress Leading to Genetic Instability Transmitted to Daughter Cells
28. Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation
29. How Can a Polymeric Formula Induce Remission in Crohn’s Disease Patients?
30. mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-BMPR1A deletion
31. Colitis Linked to Endoplasmic Reticulum Stress Induces Trypsin Activity Affecting Epithelial Functions
32. Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: A European Society for Paediatric Gastroenterology Hepatology and Nutrition Position Paper
33. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis
34. An ESPGHAN Position Paper on the Use of Breath Testing in Paediatric Gastroenterology
35. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders
36. Optimization of biologics to reduce treatment failure in inflammatory bowel diseases
37. Diagnostic de la dénutrition de l’enfant : recommandation de bonne pratique HAS-FFN 2019
38. Corrigendum to: Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study
39. Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis
40. Diagnostic de la dénutrition de l’adulte de moins de 70 ans : recommandation de bonne pratique HAS-FFN 2019
41. Safety of Thiopurine Use in Paediatric Gastrointestinal Disease
42. Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients
43. Drugs in Focus: The Use of Racecadotril in Paediatric Gastrointestinal Disease
44. Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer
45. Pediatric Magnet Ingestion, Diagnosis, Management, and Prevention: A European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Position Paper
46. Experience of Using a Semielemental Formula for Home Enteral Nutrition in Children: A Multicenter Cross-sectional Study
47. Management of Juvenile Polyposis Syndrome in Children and Adolescents: A Position Paper From the ESPGHAN Polyposis Working Group
48. Sustainable Positive Response to Sirolimus in Juvenile Polyposis of Infancy
49. NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis
50. Sustainable Positive Response to Sirolimus in Juvenile Polyposis of Infancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.